Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.

Ko YL, Hsu LA, Hsu TS, Tsai CT, Teng MS, Wu S, Chang CJ, Lee YS.

Hum Genet. 2006 Mar;119(1-2):84-91. Epub 2005 Dec 14.

PMID:
16362348
2.

Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.

Le Gal G, Delahousse B, Lacut K, Malaviolle V, Regina S, Blouch MT, Couturaud F, Mottier D, Oger E, Gruel Y; Groupe d'Etudes sur la Thrombose des Hôpitaux Universitaires du Grand Ouest.

Thromb Res. 2007;121(3):333-8. Epub 2007 Jun 12.

PMID:
17568659
3.

Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.

Nowak-Göttl U, Weiler H, Hernandez I, Thedieck S, Seehafer T, Schulte T, Stoll M.

Blood. 2009 Aug 27;114(9):1947-53. doi: 10.1182/blood-2009-04-218727. Epub 2009 Jun 10.

4.

Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study.

Heit JA, Petterson TM, Owen WG, Burke JP, DE Andrade M, Melton LJ 3rd.

J Thromb Haemost. 2005 Apr;3(4):710-7.

5.

The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.

Rasmussen-Torvik LJ, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Rosamond WD, Folsom AR.

Thromb Res. 2007;121(1):1-7. Epub 2007 Apr 11.

6.

[A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].

Liang L, Sun C, Liao XP, Xiao F, Chen XD, Huang SX, Tang XL, Wen GQ, Long ZG, Wang XY, Liu GX, Cheng S, Cai WW.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Jun;23(3):316-9. Chinese.

PMID:
16767673
7.

Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Reiner AP, Carty CL, Carlson CS, Wan JY, Rieder MJ, Smith JD, Rice K, Fornage M, Jaquish CE, Williams OD, Tracy RP, Lewis CE, Siscovick DS, Boerwinkle E, Nickerson DA.

J Thromb Haemost. 2006 Jun;4(6):1279-87.

8.

Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?

Oguzulgen IK, Ekim N, Erkekol FO, Altinok B, Akar N.

J Thromb Thrombolysis. 2005 Feb;19(1):61-3.

PMID:
15976969
9.

[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].

Titov BV, Barsova RM, Martynov MIu, Nikonova AA, Favorov AV, Gusev EI, Favorova OO.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):93-102. Russian.

PMID:
22642105
10.
11.

[Negative association of FGA gene 128C/G polymorphism with cerebral infarction and its effect on plasma fibrinogen in Hunan Hans].

Gu WP, Song XM, Gong JE, Liang J, Xiao H, Tang CL, Dong RZ, Yang QD.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Jun;27(3):286-9. doi: 10.3760/cma.j.issn.1003-9406.2010.0.011. Chinese.

PMID:
20533267
12.

P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.

Ay C, Jungbauer LV, Kaider A, Koder S, Panzer S, Pabinger I, Mannhalter C.

Thromb Haemost. 2008 May;99(5):899-904. doi: 10.1160/TH07-11-0672.

PMID:
18449419
13.

Fibrinogen alpha and beta gene polymorphisms in pediatric stroke--case-control and family based study.

Kopyta I, Niemiec P, Balcerzyk A, Emich-Widera E, Pilarska E, Pienczk-Ręcławowicz K, Kaciński M, Wendorff J, Nowak T, Iwanicki T, Sarecka-Hujar B, Zak I.

Eur J Paediatr Neurol. 2015 Mar;19(2):176-80. doi: 10.1016/j.ejpn.2014.11.011. Epub 2014 Dec 9.

PMID:
25555432
14.

Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):892-8.

15.

Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: results from the MONICA/KORA study.

Kolz M, Baumert J, Gohlke H, Grallert H, Döring A, Peters A, Wichmann HE, Koenig W, Illig T.

Thromb Haemost. 2009 Feb;101(2):317-24.

PMID:
19190816
16.

Fibrinogen gene variation and ischemic stroke.

Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C.

J Thromb Haemost. 2008 Jun;6(6):897-904. doi: 10.1111/j.1538-7836.2008.02950.x. Epub 2008 Mar 7.

17.

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

Roselli M, Ferroni P, Rolfo C, Peeters M, Palmirotta R, Formica V, Ludovici G, Laudisi A, De Marchis ML, La Farina F, Russo A, Guadagni F.

Ann Oncol. 2013 Oct;24(10):2571-5. doi: 10.1093/annonc/mdt251. Epub 2013 Jul 12.

PMID:
23852308
18.

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matsumoto ME, Petterson TM, De Andrade M.

J Thromb Haemost. 2012 Aug;10(8):1521-31. doi: 10.1111/j.1538-7836.2012.04810.x.

19.
20.

Fibrinogen polymorphisms TaqI, HaeIII and BclI are not associated with a higher risk of deep vein thrombosis.

Bozic M, Teran N, Peterlin B, Stegnar M.

Pathophysiol Haemost Thromb. 2003 May-Jun;33(3):164-9.

Supplemental Content

Support Center